(PRWEB) February 22, 2013
The US Drug Watchdog says , "We are trying to do something incredibly important for a victim of a transvaginal mesh failure in every US state by providing them with the names, and contacts of national caliber attorneys, who are women, and who also have a medical background. We are not aware of any other group in the nation offering this vital service. Because the damages associated with a transvaginal mesh failure are so gender specific, and in many cases so severe we think this is the right thing to do for these victims." According to court records a transvaginal mesh failure occurs when the mesh fails to bind to a woman's pelvic tissues. As a consequence of this, the body rejects the mesh that has been sewn into it. As a result, the transvaginal mesh may start to poke its way through the vaginal wall and protrude out of the vaginal tissue. This complication is more commonly referred to as "erosion." The US Drug Watchdog is urging any woman, who has had the transvaginal mesh surgical procedure done, and now has developed severe complications to call them anytime at 866-714-6466. http://USDrugWatchdog.Com
The US Drug Watchdog is indicating symptoms of a transvaginal mesh implant failure may include:
The US Drug Watchdog says, "One of the biggest problems we have with respect to our failed medical device or recalled drug initiative work is the average US consumer never hears about a drug recall or failures involving medical devices like a transvaginal mesh. If you have a friend, or loved one who is a recipient of a transvaginal mesh that has already failed or is showing symptoms of a failure, please have them call us at 866-714-6466. We want to make certain all transvaginal mesh failure victims get to the best possible attorneys, to ensure they get the best possible compensation for their ordeal, and we will do our absolute best to make certain all of the attorneys are women." http://USDrugWatchdog.Com
U.S. District Court for the Southern District of West Virginia Multidistrict litigation (MDL) consolidates all similar cases into one courtroom and will include the Defendants:
C.R. Bard, Inc., (MDL No. 2187);
American Medical Systems Inc., MDL No. 2325);
Boston Scientific Corp., (MDL No. 2326); and Johnson & Johnson's Ethicon, Inc. (MDL No. 2327)
Read the full story at http://www.prweb.com/releases/2013/2/prweb10424789.htm.
Copyright©2012 Vocus, Inc.
All rights reserved